Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
185 Leser
Artikel bewerten:
(1)

Biolog, Inc.: Biolog Expands the Odin Family, and Access to Cellular Characterization, With the Launch of Odin VIII

HAYWARD, CA / ACCESSWIRE / April 16, 2024 / Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic and metabolic profiling products and services, today announced the launch of OdinTM VIII system, the newest member of its Odin family of instruments. Designed to meet the needs of laboratories with mid-throughput requirements, Odin VIII is a smaller yet equally powerful version of the Odin platform introduced last year.

Odin family

Odin family
Microbial Characterization Platform



Biolog is thrilled to offer Odin VIII as a versatile solution for laboratories seeking high-performance cellular analysis capabilities in a more compact form. "Following the success of Odin in the market, we recognize the need to cater to laboratories with varying throughput requirements," said Robert Wicke, CEO of Biolog. "With Odin VIII, we are excited to extend the power and efficiency of the Odin platform to a broader range of users, enabling them to characterize cells and identify unknown organisms with unmatched ease and flexibility."

Odin VIII retains the all-in-one functionality that has made Odin a preferred choice among researchers studying how microbes respond to their environment. Leveraging the same detection methods and the ability to read and analyze any Biolog microplate, Odin VIII enables the measurement of both respiration and growth dynamics, providing valuable insights into cellular physiology and metabolic activity. Odin VIII can simultaneously incubate and read up to eight plates at once, offering the ability to streamline workflows and enhance productivity without compromising on performance. The original Odin instrument is being renamed to Odin L, to reflect its 50-plate capacity and unmatched scalability, especially important for labs with multiple users or those screening many strains at the same time. Both Odin L and Odin VIII are powered by the same Odin analytical software and share the same identification databases.

With the launch of Odin VIII, Biolog reaffirms its commitment to customer-centric solutions, empowering laboratories of all sizes to accelerate their microbial identification and characterization efforts with confidence. "This smaller system is well suited for academic research labs, fermentation departments that want to characterize or QC strains, or for researchers in sustainable agriculture studying microbiome communities. Additionally, for our customers whose environmental monitoring needs have grown, but still don't quite need the full capacity of an Odin L, we now have a medium throughput solution for in-house identification of bacteria, anaerobes, yeast, and filamentous fungi. We remain committed to empowering scientists with the tools they need to unlock the mysteries of microbial behavior," said Wicke.

To learn where to see Odin VIII at an upcoming tradeshow and for more information about Odin VIII and the complete range of Biolog's microbial analysis solutions, please visit www.biolog.com.

Contact Information

John Proctor, Ph.D.
CCO
jproctor@biolog.com
(408)306-0414

Related Files

00A 098 Rev C Odin_Brochure-RGB

SOURCE: Biolog, Inc.

.

View the original press release on newswire.com.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.